PCA: 25 Years in the Making: Where Are We Now?

Faculty & Disclosures

Sheryl Redlin Frazier, RN, MSN, OCN®
Clinical Learning Consultant
Nursing Education & Development -
Vanderbilt Medical Center
Nashville, TN

Sheryl Redlin Frazier is currently co-lead of the Vanderbilt Nurse Residency Program, a partnership with AACN-UHC. In that capacity, she develops curricula for nurse residents, preceptor workshops, and hospital initiatives such as learning modules for nurses. Sheryl has co-chaired the multidisciplinary Nursing Pharmacy Committee for 5 years. Sheryl is also a member of the ADE (Adverse Drug Events) Committee, and is charged with initiating process improvement and surveillance of high-alert medications. In addition, she is the Chair of the Nursing Education Oversight Committee, which is responsible for the program development for continuing education opportunities. As a Staff Nurse Educator, Sheryl has developed programs for competency assessment of RNs, LPNs, care partners (unlicensed assistive personnel), and medical receptionists.

Mark Sullivan, PharmD, MBA, BCPS
Director, VUH Pharmacy Operations
Vanderbilt University Hospital
Nashville, TN

Mark Sullivan is currently the Director for VUH Pharmacy Operations for the Vanderbilt University Hospital in Nashville. He has been either responsible for or assisted with implementation of a number of medication-related systems, including automated medication vending systems, the Smart Pump medication infusion system, the computerized prescriber order entry system, and the bedside barcoding system. Mark currently serves as an invited member of the USP Safe Medication Use Committee, and holds faculty appointments to the University of Tennessee College of Pharmacy. He served on the Admissions Committee for the inaugural class of the Lipscomb College of Pharmacy.

Faculty Disclosure

It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation.

Sheryl Redlin Frazier and Mark Sullivan have reported that they have no significant financial or commercial relationships to disclose.

Program Information

Return to PCA: 25 Years in the Making: Where Are We Now?

The material presented here does not reflect the views of Pharmacy Choice, Inc., ProCE, Inc., RxSchool, Hospira, Inc. or the companies providing educational content. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.